BioSpace News Archive

Apellis Pharmaceuticals, Inc. a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company will participate in the following upcoming investor conferences in September

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a company overview at the Virtual Life Sciences Investor Forum, which is being held on Thursday, September 17.

Precision BioSciences, Inc., a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, announced its participation in the following upcoming investor conferences:

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced that the company plans to participate in two upcoming conferences.

TELA Bio, Inc., a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced that the company plans to participate in two upcoming conferences.

Iterum Therapeutics plc, a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, announced revised results of its pending rights offering.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that Michael Kauffman, MD, PhD, Chief Executive Officer of Karyopharm, will participate in a fireside chat at Baird’s 2020 Global Healthcare Conference and at the Morgan Stanley 18th Annual Global Healthcare Conference.

Today, Florence announced a collaboration with Pfizer to support a global Phase 2/3 COVID-19 vaccine study.

Heat Biologics, Inc. today announced it has been issued a patent (US Patent No. 10,758,611)

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the 2020 Wells Fargo Virtual Healthcare Conference, which is being held September 9-10, 2020.